heart failure
- Technology
Managing the Rise of Heart Failure in India
In India, heart failure affects roughly 8 to 10 million people,[1] prompting 1.8 million hospitalizations annually Research suggests COVID is…
Read More » - Health
CHMP issues positive opinion for Jardiance® (empagliflozin) for the treatment of adults with heart failure with reduced ejection fraction
Ingelheim, Germany: – The positive opinion is based on the EMPEROR-Reduced trial, which showed a significant 25 percent reduction in…
Read More » - Business Wire
First patient enrolled in CARE-HK in HF to evaluate role of Veltassa® (patiromer) in enabling RAASi treatment
CARE-HK in heart failure (HF) is the first global registry of around 5,000 patients with chronic HF who have or…
Read More » - Business
Full Results From AFFIRM-AHF Study Show Ferinject® Significantly Reduces Hospitalizations After Acute Heart Failure in Patients With Iron Deficiency
St. Gallen, Switzerland: Ferinject® significantly reduced the incidence of heart failure hospitalizations in patients with iron deficiency after acute heart failure…
Read More » - Technology
Medtronic Launches World’s First Pacemaker That Can Communicate Directly With Patients’ Smartphones and Tablets
Mumbai, Maharashtra, India: India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc (NYSE:MDT), today announced the launch of the Azure™ pacemaker…
Read More » -
Why Black Aging Matters, Too
By Judith Graham| September 3, 2020 Old. Chronically ill. Black. People who fit this description are more likely to die…
Read More » - United States
Empagliflozin reduced the combined relative risk of cardiovascular death and hospitalization for heart failure by 25 percent in adults with and without diabetes who had heart failure with reduced ejection fraction
Ingelheim, Germany & Indianapolis, United States: Empagliflozin also significantly reduced the relative risk of first and recurrent hospitalization for heart…
Read More »